ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Encourages New Regional Cooperative Groups

November 19, 1976

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

October 23, 1981

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

CTEP Deploys Website To Track Trial Activation

December 10, 2010

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995